2022 Revenues ($USD) : $5,710,100,000
2022 R&D spend : $671,000,000
2022 Number of Employees : 9,793
Fiscal Year End : 12/31/2021
Company CEO : Gary Guthart, president & CEO

Since its founding in the 1990s, Intuitive has pioneered robotic surgery. It remains the dominant player in the space, even as a host of companies of all sizes have entered the field to compete. Intuitive’s present systems on the market include the Da Vinci Xi, Da Vinci X, Da Vinci SP, and Ion.

Work continues on the next generations of Intuitive’s robotic systems, CEO Gary Guthart said during the company’s Q2 earnings call in July  Guthart, however, also acknowledged that deeper technological opportunities and clinical impact also mean deeper validation work. “And we’re not afraid of that work. I’d rather do things that are really clinically meaningful for the customer,” he said. (Guthart will deliver a keynote at DeviceTalks West, Oct. 19–20, 2022 in Santa Clara, California.) –CN